IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Library CD
Volume 10, 2006 Archive
Six back issues from 2006 on one convenient archive.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $200.00


(Select Format)
Mailed CD
Instant PDF Download

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 10 No. 1 January/February 2006 Sports Medicine
Vol. 10 No. 2 March/April 2006 Hospice/Palliative Care
Vol. 10 No. 3 May/June 2006 Hormone Replacement Therapy
Vol. 10 No. 4 July/August 2006 Sterile Preparations
Vol. 10 No. 5 September/October 2006 Dermatology
Vol. 10 No. 6 November/December 2006 Veterinary Compounding

Volume 10, 2006 Articles

Volume 10, 2006 Articles
Title (Click for Details) Vol/Issue Page
PreScription: A Decade of IJPC Vol. 10 No. 1 2
CompoundingToday.com: Literature, Book Reviews, & More Vol. 10 No. 1 5
Compounding Pharmacy: The Past Decade Vol. 10 No. 1 6
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh Vol. 10 No. 1 9
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery Vol. 10 No. 1 14
Pharmaceutical Legislation: An Historical Perspective Vol. 10 No. 1 20
Pharmacy Compounding Urban Legends Vol. 10 No. 1 32
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Vol. 10 No. 1 36
Quality Control Analytical Methods: Common Concerns about Out-of-Specification Results Vol. 10 No. 1 41
Acacia and Mineral Oil Emulsion NF Vol. 10 No. 1 44
How'd They Do That? Vol. 10 No. 1 46
Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success Vol. 10 No. 1 50
Standard Operating Procedure: Shipping of Prescriptions Vol. 10 No. 1 56
Calculations Vol. 10 No. 1 58
Chlorambucil 2-mg/mL Oral Liquid Vol. 10 No. 1 59
Dantrolene Sodium 5-mg/mL Oral Liquid Vol. 10 No. 1 60
Domperidone 1-mg/mL Oral Liquid Vol. 10 No. 1 61
Efavirenz 20-mg/mL Oral Liquid, Anhydrous Vol. 10 No. 1 62
Medium-Chain Triglycerides Oral Vehicle, Anhydrous Vol. 10 No. 1 63
Mercaptopurine 50-mg/mL Oral Liquid Vol. 10 No. 1 64
Misoprostol 1-mg Suppository Vol. 10 No. 1 65
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid Vol. 10 No. 1 66
Propylthiouracil 5-mg/mL Oral Liquid Vol. 10 No. 1 67
Thioguanine 40-mg/mL Oral Liquid Vol. 10 No. 1 68
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Vol. 10 No. 1 69
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Vol. 10 No. 1 74
Scientific and Professional Reviewers for 2005 Vol. 10 No. 1 79
PostScription: Stopping Drug Reps at the Door Vol. 10 No. 1 80
PreScription: The Squeaky Wheel Gets the Grease! Vol. 10 No. 2 82
Erratum: Allen LV Jr. Lidocaine hydrochloride 2%, misoprostol 0.0024%, and phenytoin 2% topical wound powder. IJPC 2004; 8(4): 298 Vol. 10 No. 2 82
Compounding Pharmacy: The Past Decade, Part 2 -- Equipment Advances Vol. 10 No. 2 86
Hospice from a Compounding Pharmacist's Perspective Vol. 10 No. 2 89
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Vol. 10 No. 2 95
The Story of Hospice Vol. 10 No. 2 100
The Dying Process Vol. 10 No. 2 103
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives Vol. 10 No. 2 107
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist Vol. 10 No. 2 113
Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations Vol. 10 No. 2 122
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1 Vol. 10 No. 2 128
Standard Operating Procedure: Labconco Basic 47 Laboratory Hood Vol. 10 No. 2 135
Calculations Vol. 10 No. 2 136
Amlodipine 1-mg/mL Oral Liquid Vol. 10 No. 2 137
Chloroquine Phosphate 15-mg/mL Oral Liquid Vol. 10 No. 2 138
Cimetidine 60-mg/mL Oral Liquid, Alcohol Free Vol. 10 No. 2 139
Disopyramide Phosphate 1-mg/mL Oral Liquid Vol. 10 No. 2 140
Mycophenolate Mofetil 50-mg/mL Oral Liquid Vol. 10 No. 2 141
Norfloxacin 20-mg/mL Oral Liquid Vol. 10 No. 2 142
Saquinavir 60-mg/mL Oral Liquid Vol. 10 No. 2 143
Sotalol Hydrochloride 5-mg/mL Oral Liquid Vol. 10 No. 2 144
Terbinafine Hydrochloride 25-mg/mL Oral Liquid Vol. 10 No. 2 145
Trazodone Hydrochloride 10-mg/mL Oral Liquid Vol. 10 No. 2 146
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Vol. 10 No. 2 147
Chemical Stability of Diclofenac Sodium Injection Vol. 10 No. 2 154
Extended Stability of Oxytocin in Common Infusion Solutions Vol. 10 No. 2 156
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol Vol. 10 No. 2 159
PreScription: Standards, Legal Standards, and Accreditation Vol. 10 No. 3 162
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Vol. 10 No. 3 165
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor Vol. 10 No. 3 172
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Vol. 10 No. 3 175
Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update Vol. 10 No. 3 187
Probiotic Therapy, Part 2: Clinical Perspectives Vol. 10 No. 3 195
Quick Tips for Managing Market Directors Vol. 10 No. 3 201
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Vol. 10 No. 3 202
Basics of Compounding for Dentistry, Part 2: Tooth Whitening Vol. 10 No. 3 205
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Vol. 10 No. 3 208
Wise Buys: Choosing the Right Software for a Compounding Pharmacy Vol. 10 No. 3 213
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions Vol. 10 No. 3 218
Calculations Vol. 10 No. 3 219
Carvedilol 1.25-mg/mL Oral Suspension Vol. 10 No. 3 220
Enalapril Maleate 1-mg/mL Oral Suspension Vol. 10 No. 3 221
Granisetron 0.05-mg/mL Oral Suspension Vol. 10 No. 3 222
Lamotrigine 1-mg/mL Oral Suspension Vol. 10 No. 3 223
Mesna 20-mg/mL Syrup Vol. 10 No. 3 224
Mexiletine Hydrochloride 10-mg/mL Oral Suspension Vol. 10 No. 3 225
Pyrimethamine 2-mg/mL Oral Suspension Vol. 10 No. 3 226
Quinapril 1-mg/mL Oral Liquid Vol. 10 No. 3 227
Theophylline 5-mg/mL Oral Liquid, Alcohol-Free Vol. 10 No. 3 228
Triamcinolone Acetonide 0.1% Mouthwash Solution Vol. 10 No. 3 229
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Vol. 10 No. 3 230
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Vol. 10 No. 3 234
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together Vol. 10 No. 3 237
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! Vol. 10 No. 3 240
PreScription: 6-Year or 7-Year Program? Vol. 10 No. 4 242
Introduction to Hospital Compounding Vol. 10 No. 4 245
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations Vol. 10 No. 4 253
Putting the Science Back into the "Art and Science" of Compounding Vol. 10 No. 4 263
Compounded Treatment Options for Cystitis and Other Bladder Problems Vol. 10 No. 4 270
Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces Vol. 10 No. 4 277
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist Vol. 10 No. 4 281
What are You Willing to Do? Vol. 10 No. 4 287
Hospice Symptom Relief Kit: An Update Vol. 10 No. 4 288
Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight Vol. 10 No. 4 291
Aseptic Compounding in New Zealand and the Use of Still Air Boxes Vol. 10 No. 4 293
Standard Operating Procedure: Testing of Water Supply: Barnstead D4751 High Purity Water System Vol. 10 No. 4 296
Calculations Vol. 10 No. 4 298
Adderall 1-mg/mL Oral Liquid Vol. 10 No. 4 299
Dapsone 2-mg/mL Oral Liquid Vol. 10 No. 4 300
Itraconazole 40-mg/mL Oral Liquid Vol. 10 No. 4 301
Lisinopril 1-mg/mL Oral Liquid Vol. 10 No. 4 302
Nifedipine 4-mg/mL Oral Liquid Vol. 10 No. 4 303
Propranolol Hydrochloride 1-mg/mL Oral Liquid Vol. 10 No. 4 304
Rifabutin 20-mg/mL Oral Liquid Vol. 10 No. 4 305
Sildenafil Citrate 2.5-mg/mL Oral Liquid Vol. 10 No. 4 306
Tramadol Hydrochloride 5-mg/mL Oral Liquid Vol. 10 No. 4 307
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid Vol. 10 No. 4 308
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729> Vol. 10 No. 4 309
Stability of Memantine in an Extemporaneously Prepared Oral Liquid Vol. 10 No. 4 316
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free Vol. 10 No. 4 318
PostScription: Patients or Clients? Vol. 10 No. 4 320
PreScription: Certification and Accreditation Vol. 10 No. 5 322
Topical Cidofovir for Treatment of Resistant Viral Infections Vol. 10 No. 5 324
Mesotherapy: Cosmetic Applications Vol. 10 No. 5 331
Dermatological Effects from Years in the Sun: Compounding Opportunities Vol. 10 No. 5 336
Migraine: A General Approach to Prevention and Treatment Vol. 10 No. 5 344
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches Vol. 10 No. 5 351
University of North Carolina at Chapel Hill School of Pharmacy Pharmaceutical Care Laboratories: Compounding Laboratory Curriculum and Renovation Vol. 10 No. 5 353
Education, Training, and Evaluation of Hospital Compounding Personnel Vol. 10 No. 5 361
MEDLINE: A Valuable Research Tool for the Compounding Pharmacist Vol. 10 No. 5 369
Quality-Control Analytical Methods: Sterility Failure Investigations Vol. 10 No. 5 372
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction Vol. 10 No. 5 377
Calculations Vol. 10 No. 5 380
Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations Vol. 10 No. 5 381
Famotidine 8-mg/mL Oral Liquid Vol. 10 No. 5 382
Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration Vol. 10 No. 5 383
Hydroxyurea 100 mg/mL Vol. 10 No. 5 384
Indinavir 10-mg/mL Oral Liquid Vol. 10 No. 5 385
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid Vol. 10 No. 5 386
Midazolam Hydrochloride 1-mg/mL Oral Liquid Vol. 10 No. 5 387
Nitrazepam 1-mg/mL Oral Liquid Vol. 10 No. 5 388
Omeprazole 2-mg/mL Oral Liquid Vol. 10 No. 5 389
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Vol. 10 No. 5 390
Pantoprazole Sodium 2-mg/mL Oral Liquid Vol. 10 No. 5 391
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Vol. 10 No. 5 392
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Vol. 10 No. 5 396
PostScription: Moving Pharmacy Compounding into the 21st Century and Beyond Vol. 10 No. 5 400
PreScription: International Journal of Pharmaceutical Compounding is Expanding Vol. 10 No. 6 402
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Vol. 10 No. 6 405
Compounding for Feline Herpetic Keratitis Vol. 10 No. 6 411
Compounding for Veterinary Medicine Vol. 10 No. 6 417
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety Vol. 10 No. 6 418
Taurine for the Treatment of Canine Dilated Cardiomyopathy Vol. 10 No. 6 421
Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard) Vol. 10 No. 6 426
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Vol. 10 No. 6 428
Ronidazole in the Treatment of Trichomonad Infections in Cats Vol. 10 No. 6 434
Equipment, Supplies, and Facilities Required for Hospital Compounding Vol. 10 No. 6 436
Quality Control Analytical Methods: Continuous Quality Improvement Vol. 10 No. 6 442
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Vol. 10 No. 6 446
Calculations: Compounding for Large and Small Animals Vol. 10 No. 6 449
Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies Vol. 10 No. 6 450
Amiloride Hydrochloride 1-mg/mL Oral Liquid Vol. 10 No. 6 452
Chloral Hydrate 50-mg/mL Oral Liquid Vol. 10 No. 6 453
Cyclophosphamide 2-mg/mL Oral Liquid Vol. 10 No. 6 454
Disulfiram 25-mg/mL Oral Liquid Vol. 10 No. 6 455
Gabapentin 100-mg/mL Oral Liquid Vol. 10 No. 6 456
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid Vol. 10 No. 6 457
Indomethacin 2-mg/mL Oral Liquid Vol. 10 No. 6 458
Naltrexone 1-mg/mL Oral Liquid Vol. 10 No. 6 459
Terbutaline Sulfate 1-mg/mL Oral Liquid Vol. 10 No. 6 460
Valacyclovir 50-mg/mL Oral Liquid Vol. 10 No. 6 461
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Vol. 10 No. 6 462
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations Vol. 10 No. 6 469
PostScription: Challenges Facing an Analytical Laboratory Vol. 10 No. 6 479